Caelyx - Information, specialists, frequent questions.

Usage of Caelyx

Indications: Advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. AIDS-related Kaposi's sarcoma (KS) in patients with low CD4 counts (<200 CD lymphocytes/mm3) and extensive mucocutaneous or 4 visceral disease. Caelyx may be used as first-line systemic chemotherapy, or as second line chemotherapy in AIDS-KS patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline)
Contra Indications: History of hypersensitivity reactions to components of Caelyx or to doxorubicin. Pregnancy and lactation. Should not be used to treat AIDS Kaposi's sarcoma that may be effectively treated with local therapy or systemic alfa- interferon

Adverse and side effects

Leucopenia, thrombocytopenia, anaemia. Refer to Summary of Product Characteristics

Special precautions

Cardiac risk, myelosuppression: see Summary of Product Characteristics. Diabetic patients: it should be noted that each vial of Caelyx contains sucrose and is administered in 5% (50mg/mL) glucose intravenous infusion

What professionals prescribe Caelyx?


All the contents published in Doctoralia.co.uk, especially medical question and answers, are informative and in no case must be considered a substitute for medical advice.